Literature DB >> 25331193

Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid.

Meiki Yu1, Joseph E Ocando, Louis Trombetta, Parnali Chatterjee.   

Abstract

Betulinic acid (BA), a novel natural product with antimelanoma activity, has poor aqueous solubility (<0.1 μg/mL) and therefore exhibits poor bioavailability. The purpose of this study was to explore the feasibility of preparing BA solid dispersions (BA-SDs) with hydrophilic polymers to enhance the aqueous solubility of BA. Melt-quenched solid dispersions (MQ-SDs) of BA were prepared at various ratios with the hydrophilic polymers including Soluplus, HPMCAS-HF, Kollidon VA64, Kollidon K90, and Eudragit RLPO. BA was found to be miscible in all polymers at a 1:4 (w/w) ratio by modulated differential scanning calorimetry (MDSC). BA/Soluplus MQ-SD exhibited the highest solubility in simulated body fluids followed by BA/Kollidon VA64 MQ-SD. The MQ-SDs of BA/Soluplus, BA/HPMCAS-HF, and BA/Kollidon VA64 were found to be amorphous as indicated by X-ray powder diffraction (XRPD) studies. Fourier transform infra-red (FT-IR) studies indicated molecular interactions between BA and Soluplus. Our preliminary screening of polymers indicates that Soluplus and Kollidon VA64 exhibit the greatest potential to form BA-SDs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25331193      PMCID: PMC4370963          DOI: 10.1208/s12249-014-0220-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  36 in total

Review 1.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

Authors:  Chau Le-Ngoc Vo; Chulhun Park; Beom-Jin Lee
Journal:  Eur J Pharm Biopharm       Date:  2013-09-18       Impact factor: 5.571

Review 2.  Cytotoxic anticancer candidates from natural resources.

Authors:  Jinwoong Kim; Eun Jung Park
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-07

Review 3.  Assessing the performance of amorphous solid dispersions.

Authors:  Ann Newman; Gregory Knipp; George Zografi
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

4.  Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay.

Authors:  Cristina A Dehelean; Stefana Feflea; Srinivas Ganta; Mansoor Amiji
Journal:  J Biomed Nanotechnol       Date:  2011-04       Impact factor: 4.099

5.  Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells.

Authors:  Valentina Zuco; Rosanna Supino; Sabina C Righetti; Loredana Cleris; Edoardo Marchesi; Carlo Gambacorti-Passerini; Franca Formelli
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

Review 6.  Highlights in the development of new antiviral agents.

Authors:  E De Clercq
Journal:  Mini Rev Med Chem       Date:  2002-04       Impact factor: 3.862

7.  Evaluation of apparent formation constants of pentacyclic triterpene acids complexes with derivatized beta- and gamma-cyclodextrins by reversed phase liquid chromatography.

Authors:  B Claude; Ph Morin; M Lafosse; P Andre
Journal:  J Chromatogr A       Date:  2004-09-17       Impact factor: 4.759

8.  Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types.

Authors:  Jan H Kessler; Franziska B Mullauer; Guido M de Roo; Jan Paul Medema
Journal:  Cancer Lett       Date:  2006-12-13       Impact factor: 8.679

9.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

10.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.